First-Trimester Ultrasound Nuchal Translucency Screening for Fetal Aneuploidy

Please note: All assessments are current as of the review date; however, new evidence that may have been published subsequently is not considered.
Review Date: February 11, 2004
Recommendation: This topic was reviewed by the California Technology Assessment Forum on February 11, 2004. It was determined that ultrasound nuchal translucency with biochemical screening for fetal aneuploidy meets technology assessment criteria and should be restricted to centers meeting California Department of Health Services designation for Perinatal Diagnostic Centers.
Decision: Does Meet CTAF Criteria
Full Assessment: Download (PDF)

Search Assessments

Email Notification

Sign up to receive email notifications of upcoming CTAF meetings and new assessments.

 


Methodology

Learn about CTAF's approach to technology assessment.

Criteria used »
Assessment Process »
Selecting Topics for Assessment »

Suggest an Assessment

Know of a new device, procedure, or test that CTAF should consider for assessment?

Contact us »
  © 2012 California Technology Assessment Forum. All rights reserved.

Contact Us | Privacy Policy | Terms of Use | Credits